Selective Serotonin Reuptake Inhibitor and Substance P Antagonist Enhancement of Natural Killer Cell Innate Immunity in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
Dwight L. Evans(California University of Pennsylvania), Steven D. Douglas(Purdue University West Lafayette), Nancy B. Tustin(Children's Hospital of Philadelphia), David R. Gettes, Jianping Lai(Southwest University of Science and Technology), Tami D. Benton(American Academy of Child and Adolescent Psychiatry), B Dubé(Geological Survey of Canada), David S. Metzger(Children's Hospital of Philadelphia), Kevin G. Lynch(Philadelphia VA Medical Center)
Cited by 70
Related Papers
Mood Disorders in the Medically Ill: Scientific Review and Recommendations
|Biological Psychiatry|2005|1.1k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
What Is Community? An Evidence-Based Definition for Participatory Public Health
|American Journal of Public Health|2001|768
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390